Revlimid Oral Capsule 10Mg Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • myWeekly Ad

Revlimid: Oral capsule (10mg)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file default-drug-image.png


What is this Medicine?

LENALIDOMIDE (len a LID oh mide) is a chemotherapy drug that targets specific proteins within cancer cells and stops the cancer cell from growing. It is used to treat multiple myeloma, mantle cell lymphoma, and some myelodysplastic syndromes that cause severe anemia requiring blood transfusions.

In-Depth Information

Revlimid 10mg Capsule

NDC: 595720410
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Mantle Cell Lymphoma (MCL), Multiple Myeloma, Myelodysplastic Syndrome (MDS)

Storage Information
Store between 68 to 77 degrees F, excursions permitted 59 to 86 degrees F
Revlimid 10mg Capsule

Reported Side Effects for Revlimid 10mg Capsule

Vomiting Incidence:
<1.4%*
Severity: SEVERE
Onset: EARLY
Tumor Lysis Syndrome (TLS) Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Heart Attack Incidence:
<5.0%*
Severity: SEVERE
Onset: DELAYED
Muscle Cramps Incidence:
<2.0%*
Severity: SEVERE
Onset: DELAYED
Flu Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Infection Incidence:
<8.5%*
Severity: SEVERE
Onset: DELAYED
Stomach Pain Incidence:
<4.0%*
Severity: SEVERE
Onset: EARLY
Stevens-Johnson Syndrome Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Itching Incidence:
<2.0%*
Severity: SEVERE
Onset: RAPID
Upset Stomach Incidence:
<4.1%*
Severity: SEVERE
Onset: EARLY
Weight Loss Incidence:
<2.1%*
Severity: SEVERE
Onset: DELAYED
Weakness Incidence:
<5.7%*
Severity: SEVERE
Onset: EARLY
Lyell'S Syndrome Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Blood Clot Incidence:
<21.5%*
Severity: SEVERE
Onset: DELAYED
Rapid Heart Rate Incidence:
<1.0%*
Severity: MODERATE
Onset: EARLY
Muscle And/Or Bone Pain Incidence:
<1.0%*
Severity: SEVERE
Onset: EARLY
Rash With Pustules Incidence:
<7.3%*
Severity: SEVERE
Onset: EARLY
Metallic Taste Incidence:
<1.0%*
Severity: SEVERE
Onset: EARLY
Chest Pain Incidence:
<2.0%*
Severity: SEVERE
Onset: EARLY
Excessive Sweating Incidence:
<1.4%*
Severity: SEVERE
Onset: DELAYED
Diabetes Incidence:
<1.5%*
Severity: SEVERE
Onset: DELAYED
Upset Stomach Incidence:
<1.0%*
Severity: SEVERE
Onset: EARLY
Nose Bleed Incidence:
<1.4%*
Severity: SEVERE
Onset: DELAYED
Erythema Multiforme Incidence:
<26.1%*
Severity: SEVERE
Onset: DELAYED
Dehydration Incidence:
<3.0%*
Severity: SEVERE
Onset: DELAYED
Cough Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Low Phosphate Level Incidence:
<1.3%*
Severity: SEVERE
Onset: DELAYED
Low Blood Pressure Incidence:
<3.0%*
Severity: SEVERE
Onset: RAPID
Constipation Incidence:
<2.0%*
Severity: SEVERE
Onset: DELAYED
Inability To Sleep Incidence:
<0.8%*
Severity: MODERATE
Onset: EARLY
Headache Incidence:
<1.4%*
Severity: SEVERE
Onset: EARLY
Angioedema Incidence:
<1.0%*
Severity: SEVERE
Onset: RAPID
Decreased Appetite Incidence:
<2.6%*
Severity: SEVERE
Onset: DELAYED
Bone Pain Incidence:
<3.0%*
Severity: SEVERE
Onset: DELAYED
Gout Incidence:
<1.5%*
Severity: SEVERE
Onset: DELAYED
Secondary Malignancy Incidence:
0.4-10.0%*
Severity: MODERATE
Onset: DELAYED
Brain Attack Incidence:
0.8-2.0%*
Severity: SEVERE
Onset: EARLY
Pancytopenia Incidence:
0.9-2.0%*
Severity: SEVERE
Onset: DELAYED
Elevated Hepatic Enzymes Incidence:
1.0-8.1%*
Severity: MODERATE
Onset: DELAYED
Back Pain Incidence:
1.0-7.0%*
Severity: SEVERE
Onset: DELAYED
Hallucinations Incidence:
>1.0%*
Severity: MODERATE
Onset: EARLY
Hoarseness Incidence:
>1.0%*
Severity: MILD
Onset: EARLY
Hypoxia Incidence:
1.0-1.4%*
Severity: SEVERE
Onset: EARLY
Impotence (erectile Dysfunction) Incidence:
>1.0%*
Severity: MODERATE
Onset: DELAYED
Decreased Sexual Desire Incidence:
>1.0%*
Severity: MILD
Onset: DELAYED
Feeling Sick Incidence:
>1.0%*
Severity: MILD
Onset: EARLY
Skin Rash Incidence:
1.0-7.3%*
Severity: SEVERE
Onset: EARLY
Darkened Skin Patches Incidence:
>1.0%*
Severity: MILD
Onset: DELAYED
Slow Heart Beat Incidence:
>1.0%*
Severity: SEVERE
Onset: RAPID
Joint Pain Incidence:
1.0-1.7%*
Severity: SEVERE
Onset: DELAYED
Chest Pain Incidence:
>1.0%*
Severity: MODERATE
Onset: EARLY
Intestinal Bleeding Incidence:
>1.0%*
Severity: SEVERE
Onset: DELAYED
Low Calcium Levels Incidence:
1.0-4.3%*
Severity: SEVERE
Onset: DELAYED
High Eye Blood Pressure Incidence:
>1.0%*
Severity: SEVERE
Onset: DELAYED
Hirsutism Incidence:
>1.0%*
Severity: MILD
Onset: DELAYED
Hemolytic Anemia Incidence:
>1.0%*
Severity: SEVERE
Onset: DELAYED
Shortness Of Breath Incidence:
1.1-6.0%*
Severity: SEVERE
Onset: EARLY
Cataracts Incidence:
1.3-8.0%*
Severity: SEVERE
Onset: DELAYED
Low Blood Sodium Levels Incidence:
1.3-2.0%*
Severity: SEVERE
Onset: DELAYED
High Pressure In Lungs Incidence:
1.4%*
Severity: SEVERE
Onset: DELAYED
Lung Inflammation Incidence:
1.4%*
Severity: MODERATE
Onset: DELAYED
Fluid Around The Lungs Incidence:
1.4-7.0%*
Severity: SEVERE
Onset: DELAYED
Fainting Incidence:
1.4-2.8%*
Severity: SEVERE
Onset: EARLY
Weakness Incidence:
1.4-7.7%*
Severity: SEVERE
Onset: DELAYED
Heart Failure Incidence:
1.4%*
Severity: SEVERE
Onset: DELAYED
Rapid Heart Rate Incidence:
1.7%*
Severity: MODERATE
Onset: RAPID
Depression Incidence:
1.9-2.8%*
Severity: SEVERE
Onset: DELAYED
Fever Incidence:
2.0-3.4%*
Severity: SEVERE
Onset: EARLY
Blood Clot In Lung Incidence:
2.0-4.0%*
Severity: SEVERE
Onset: DELAYED
Low Potassium Levels Incidence:
2.0-6.6%*
Severity: SEVERE
Onset: DELAYED
Lightheadedness Incidence:
2.0-2.7%*
Severity: SEVERE
Onset: EARLY
Low Lymphocytes Incidence:
2.8-4.0%*
Severity: SEVERE
Onset: DELAYED
Loose Stools Incidence:
3.1-6.0%*
Severity: SEVERE
Onset: EARLY
Irregular Heart Beat Incidence:
3.7-7.0%*
Severity: SEVERE
Onset: EARLY
Kidney Failure Incidence:
4.0-9.2%*
Severity: SEVERE
Onset: DELAYED
Blood Clot Incidence:
4.0-10.3%*
Severity: SEVERE
Onset: DELAYED
Low White Blood Cell Counts Incidence:
4.0-7.0%*
Severity: SEVERE
Onset: DELAYED
Tired Incidence:
4.7-7.3%*
Severity: SEVERE
Onset: EARLY
Night Sweats Incidence:
5.0-10.0%*
Severity: MILD
Onset: EARLY
Nerve Pain Incidence:
5.0-10.0%*
Severity: MODERATE
Onset: DELAYED
Chills Incidence:
5.0-10.0%*
Severity: MILD
Onset: RAPID
Sore Throat Incidence:
5.0-23.0%*
Severity: MILD
Onset: DELAYED
Dry Skin Incidence:
5.0-14.2%*
Severity: MILD
Onset: DELAYED
Sinus Infection Incidence:
5.0-10.0%*
Severity: MILD
Onset: DELAYED
Skin Redness Incidence:
5.4%*
Severity: MODERATE
Onset: EARLY
Bruise Incidence:
5.4%*
Severity: MILD
Onset: DELAYED
Rapid Heart Rate Incidence:
5.4%*
Severity: MODERATE
Onset: EARLY
Rhinitis Incidence:
5.5-6.8%*
Severity: MILD
Onset: EARLY
Anemia Incidence:
6.1-18.2%*
Severity: SEVERE
Onset: DELAYED
Low Magnesium Levels Incidence:
6.1-6.8%*
Severity: MODERATE
Onset: DELAYED
High Blood Pressure Incidence:
6.1-7.9%*
Severity: MODERATE
Onset: EARLY
Increased Blood Sugar Incidence:
6.4%*
Severity: MODERATE
Onset: DELAYED
Dry Mouth Incidence:
6.8-7.1%*
Severity: MILD
Onset: EARLY
Underactive Thyroid Incidence:
6.8%*
Severity: MODERATE
Onset: DELAYED
Tiredness Incidence:
6.8%*
Severity: MILD
Onset: EARLY
Hypoesthesia Incidence:
6.8-10.8%*
Severity: MILD
Onset: DELAYED
Painful Urination Incidence:
6.8%*
Severity: MODERATE
Onset: EARLY
Low Platelet Count Incidence:
8.3-50.0%*
Severity: SEVERE
Onset: DELAYED
Muscle Pain Incidence:
8.8%*
Severity: MILD
Onset: EARLY
Enlarged Lymph Nodes Incidence:
10.0%*
Severity: MODERATE
Onset: DELAYED
Swelling Incidence:
10.1%*
Severity: MODERATE
Onset: DELAYED
Fluid Retention Incidence:
16.0-26.3%*
Severity: MODERATE
Onset: DELAYED
Blurred Vision Incidence:
17.3%*
Severity: MODERATE
Onset: EARLY
Shaking Incidence:
21.2%*
Severity: MILD
Onset: EARLY
Low White Blood Cells Incidence:
27.8-53.4%*
Severity: SEVERE
Onset: DELAYED
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Pregnancy & Lactation Information
FIRST Trimester

Class X - Adequate well-controlled or observational studies in animals or pregnant women have demonstrated positive evidence of fetal abnormalities or risks. The use of the product is contraindicated in women who are or may become pregnant.

SECOND Trimester

Class X - Adequate well-controlled or observational studies in animals or pregnant women have demonstrated positive evidence of fetal abnormalities or risks. The use of the product is contraindicated in women who are or may become pregnant.

THIRD Trimester

Class X - Adequate well-controlled or observational studies in animals or pregnant women have demonstrated positive evidence of fetal abnormalities or risks. The use of the product is contraindicated in women who are or may become pregnant.

Lactation

Avoid - This drug is known to cause harm to infants when taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Revlimid

Be the first to share your experience!

We want to help our customers stay educated about the medications they are taking. Submit your own observations and experiences to benefit others.

Average Scores
Easy to Take 
0 / 5
0 / 5
Works as Intended 
0 / 5
0 / 5
Tolerable 
0 / 5
0 / 5